14th European LUPUS Meeting

March 19 – 22, 2024 | Bruges, Belgium

We’re proud to attend and present at the 14th European LUPUS Meeting. The meeting’s objective is to share the latest clinical and basic advances in the field of systemic lupus erythematosus with concurrent sessions combining invited talks, oral and abstract presentations, a great debate and more.

Look for our poster presentation on Wednesday’s agenda, titled “Augmenting the potential of combined real-world connected clinical and claims data sources to characterize the heterogenous profiles of patients with lupus: A French case study (Lupus REAL).”

Events
Published on:
March 13, 2024

About Our Poster Presentation

Augmenting the potential of combined real-world connected clinical and claims data sources to characterize the heterogenous profiles of patients with lupus: A French case study (Lupus REAL)

Wednesday, March 20 @ 12:45

The heterogeneity of lupus clinical manifestations makes it difficult to precisely characterize the full spectrum of patient profiles with traditional real-life (claims) data sources. This study assesses the ability of a digital platform to characterize patients with lupus attending a reference center in France.

Poster Authors: Marc Jouve, Sancare, Paris, France; Eymeric Lagonotte, CHU Reims, France; Marion Valette, Sancare, Paris, France; Barbara Lebas, Sancare, Paris, France; Batourou Sano, Alira Health SAS, Paris, France; Elodie Lehmann, Alira Health SAS, Paris, France; Vincent Vuiblet, CHU Reims, France

About Our Presenter

Elodie Lehmann

Elodie Lehmann

Associate Director, Real-World Solutions

About the Alira Health / FORWARD Lupus Registry

Together with FORWARD, the National Databank for Rheumatic Diseases, we unlock the value of data from thousands of US Lupus patients to improve the understanding of the patient and caregiver experience and needs. Access the real-life health experience of Lupus patients to advance research, improve patient outcomes, and make better clinical decisions!

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.